Clear Impact logo R

Communicable Disease Surveillance: Monthly

Logo

Why Is This Important?

Measures

Most Recent Period
Current Actual Value
Current Target Value
Current Trend
Baseline % Change
I
Disease
Campylobacteriosis
Apr 2025
3
1
50%
I
Disease
Chlamydia
Apr 2025
31
1
-28%
I
Disease
Cryptosporidiosis
Apr 2025
1
1
0%
I
Disease
Gonorrhea (gonococcal infection)
Apr 2025
2
1
-88%
I
Disease
Haemophilus Influenzae (Invasive Disease)
Apr 2025
1
1
0%
I
Disease
Hepatitis A
Apr 2025
1
1
0%
I
Disease
Hepatitis B-Chronic Non-Perinatal
Apr 2025
3
2
50%
I
Disease
Hepatitis C-Perinatal Infection
Apr 2025
0
4
-100%
I
Disease
Hepatitis C - Chronic Non-Perinatal
Apr 2025
3
2
-40%
I
Disease
Hepatitis E
Apr 2025
0
44
0%
I
Disease
Legionellosis
Apr 2025
2
1
100%
I
Disease
Lyme Disease
Apr 2025
3
1
200%
I
Disease
Meningitis-aseptic/viral
Apr 2025
1
1
0%
I
Disease
Rabies-animal
Apr 2025
0
43
0%
I
Disease
Pertussis
Apr 2025
5
2
400%
I
Disease
Shigellosis
Jan 2025
0
4
0%
I
Disease
Streptococcal - Group A-Invasive
Apr 2025
2
1
100%
I
Disease
Syphilis
Apr 2025
0
1
0%
I
Disease
Varicella - Chickenpox
Apr 2025
0
2
0%
I
Disease
E. Coli, Shiga Toxin-Producing
Apr 2025
0
3
0%
I
Disease
Giardiasis
Apr 2025
0
4
0%
I
Disease
Hepatitis B Acute
Apr 2025
0
6
0%
I
Disease
Salmonellosis
Apr 2025
4
1
300%
I
Disease
Tuberculosis (TB)
Apr 2025
0
1
0%
I
Disease
Meningitis-bacterial
Apr 2025
0
2
-100%
I
Disease
Streptococcus pneumoniae - invasive antibiotic resistance unknown or non-resistant
Apr 2025
3
2
200%
I
Disease
Influenza-associated hospitalization
Apr 2025
1
2
0%
I
Disease
Yersiniosis
Apr 2025
0
3
0%
I
Disease
Amebiasis
Apr 2025
0
43
0%
I
Disease
Coccidioidomycosis - Valley Fever
Apr 2025
0
14
-100%
I
Disease
CP-CRE
Apr 2025
0
75
0%
I
Disease
Malaria
Apr 2025
0
5
-100%
I
Disease
Staphylococcal aureus - intermediate resistance to vancomycin (VISA)
Apr 2025
0
39
0%
I
Disease
Streptococcus pneumoniae - invasive antibiotic resistant/intermediate
Apr 2025
2
1
100%
I
Disease
Vibriosis
Apr 2025
0
10
0%
I
Disease
Tularemia
Apr 2025
0
34
0%
I
Disease
Hepatitis B-Perinatal Infection
Apr 2025
0
2
0%
I
Disease
Monkeypox
Apr 2025
0
16
0%
I
Disease
Spotted Fever Rickettsiosis, including Rocky Mountain spotted fever (RMSF)
Apr 2025
0
32
0%
I
Disease
Listeriosis
Apr 2025
0
5
0%
I
Disease
Measles
Apr 2025
0
4
-100%
I
Disease
Hepatitis C - Acute
Apr 2025
0
26
-100%
I
Disease
Mumps
Apr 2025
0
14
-100%
I
Disease
Cyclosporiasis
Apr 2025
0
7
-100%
I
Disease
Anthrax
Apr 2025
0
75
0%
I
Disease
Arboviral neuroinvasive and non-neuroinvasive disease
Apr 2025
0
75
0%
I
Disease
Babesiosis
Apr 2025
0
16
0%
I
Disease
Botulism (Foodborne)
Apr 2025
0
75
0%
I
Disease
Botulism (Infant)
Apr 2025
0
75
0%
I
Disease
Botulism (Wound)
Apr 2025
0
75
0%
I
Disease
Brucellosis
Apr 2025
0
8
0%
I
Disease
Candida auris
Apr 2025
0
2
0%
I
Disease
Chancroid
Apr 2025
0
75
0%
I
Disease
Chikungunya
Apr 2025
0
75
0%
I
Disease
Cholera
Apr 2025
0
75
0%
I
Disease
Creutfeldt-Jakob Disease
Apr 2025
0
39
0%
I
Disease
CPO - Colonization Screening
Apr 2025
0
24
0%
I
Disease
CPO
Apr 2025
0
3
0%
I
Disease
Diphtheria
Apr 2025
0
39
0%
I
Disease
Dengue
Apr 2025
0
39
0%
I
Disease
Ehrlichiosis-Ehrlichia chaffeensis
Apr 2025
0
30
0%
I
Disease
Ehrlichiosis/Anaplasmosis - Undetermined
Apr 2025
0
39
0%
I
Disease
Eastern Equine Encephalitis Virus Disease
Apr 2025
0
39
0%
I
Disease
Hemolytic Uremic Syndrome (HUS)
Apr 2025
0
17
0%
I
Disease
Hantavirus
Apr 2025
0
39
0%
I
Disease
Hepatitis D (delta virus)
Apr 2025
0
39
0%
I
Disease
Influenza A - novel virus
Apr 2025
0
39
0%
I
Disease
Influenza-associated Pediatric Mortality
Apr 2025
0
12
0%
I
Disease
LaCrosse virus disease
Apr 2025
0
39
0%
I
Disease
Leprosy (Hansen disease)
Apr 2025
0
39
0%
I
Disease
Leptospirosis
Apr 2025
0
6
0%
I
Disease
Middle East Respiratory Syndrome (MERS)
Apr 2025
0
39
0%
I
Disease
Meningococcal disease
Apr 2025
0
3
0%
I
Disease
Plague
Apr 2025
0
39
0%
I
Disease
Psittacosis
Apr 2025
0
39
0%
I
Disease
Poliomyelitis
Apr 2025
0
38
0%
I
Disease
Powassan virus Disease
Apr 2025
0
39
0%
I
Disease
Q Fever
Apr 2025
0
39
0%
I
Disease
Rubella (congenital)
Apr 2025
0
39
0%
I
Disease
Rubella (not congenital)
Apr 2025
0
39
0%
I
Disease
Salmonella Typhi infection (typhoid fever)
Apr 2025
0
39
0%
I
Disease
Samonella Paratyphi Infection
Apr 2025
0
39
0%
I
Disease
Severe acute respiratory syndrome (SARS)
Apr 2025
0
39
0%
I
Disease
Smallpox
Jan 2025
0
36
0%
I
Disease
St. Louis Encephalitis Virus Disease
Jan 2025
0
36
0%
I
Disease
Streptococcal Disease, group B., in newborn
Apr 2025
0
39
0%
I
Disease
Streptococcal Toxic Shock Syndrome (STSS)
Apr 2025
0
39
0%
I
Disease
Tetanus
Apr 2025
0
39
0%
I
Disease
Toxic Shock Syndrome
Apr 2025
0
39
0%
I
Disease
Trichinellosis
Apr 2025
0
39
0%
I
Disease
Viral Hemorrhagic Fever (VHF)
Apr 2025
0
38
0%
I
Disease
West Nile Virus
Apr 2025
0
39
0%
I
Disease
Zika Virus Infection
Apr 2025
0
39
0%
I
Disease
Yellow Fever
Apr 2025
0
39
0%
I
Disease
Western Equine Encephalitis
Apr 2025
0
39
0%
I
Disease
Anaplasmosis-Anaplasma phagocytophilum
Apr 2025
0
38
0%
Powered by Clear Impact

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy